CITATION STYLE
Lambert, J. M., O’Leary, J., Whiteman, K. R., & Goldmacher, V. S. (2013). Targeting CD56 (NCAM)-expressing neoplasms with lorvotuzumab mertansine. In Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications (pp. 273–293). Springer New York. https://doi.org/10.1007/978-1-4614-5456-4_16
Mendeley helps you to discover research relevant for your work.